(0.18%) 5 257.80 points
(0.16%) 39 824 points
(-0.08%) 16 386 points
(2.02%) $82.99
(1.75%) $1.748
(1.24%) $2 240.20
(0.89%) $24.97
(1.34%) $921.85
(0.39%) $0.927
(0.81%) $10.86
(0.13%) $0.792
(0.14%) $92.57
Live Chart Being Loaded With Signals
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases...
Stats | |
---|---|
Today's Volume | 375 912 |
Average Volume | 247 981 |
Market Cap | 42.44M |
EPS | $0 ( 2024-03-21 ) |
Next earnings date | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.608 |
ATR14 | $0.0360 (5.15%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-09-29 | Fairmount Funds Management Llc | Buy | 24 670 | Common Stock |
2023-09-26 | Fairmount Funds Management Llc | Buy | 30 000 | Common Stock |
2023-09-22 | Randhawa Simrat | Buy | 2 000 | Common Stock |
2023-09-21 | Randhawa Simrat | Buy | 2 000 | Common Stock |
2023-09-19 | Fairmount Funds Management Llc | Buy | 30 000 | Common Stock |
INSIDER POWER |
---|
-64.38 |
Last 94 transactions |
Buy: 3 902 024 | Sell: 4 691 992 |
Volume Correlation
Magenta Therapeutics Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Magenta Therapeutics Inc Correlation - Currency/Commodity
Magenta Therapeutics Inc Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-23.05 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-3.78 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-1.030 |
Q1 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-8.21 |
Financial Reports:
No articles found.
Magenta Therapeutics Inc
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that cause acute myeloid leukemia and myelodysplastic syndromes, which is under Phase I/II clinical trial; CD45-antibody drug conjugate that targets HSCs and immune cells, which is in investigational new drug application enabling studies for potential use as a single-agent in autoimmune diseases and hematology-oncology transplants; and MGTA-145 that is in Phase II clinical trial for use in autologous and allogeneic transplants. The company also has a cell therapy program, E478, which is a small molecule aryl hydrocarbon receptor antagonist for stem cell-based gene therapy and genome editing. Magenta Therapeutics, Inc. has a research and clinical collaboration agreement with AVROBIO, Inc. for the treatment of lysosomal storage disorders; and Beam Therapeutics, Inc. to evaluate the potential utility of MGTA-117 for conditioning of patients with sickle cell disease and beta-thalassemia. The company was formerly known as HSCTCo Therapeutics, Inc. and changed its name to Magenta Therapeutics, Inc. in February 2016. Magenta Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators